Open Access

MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2 Corrigendum in /10.3892/mmr.2018.8785

Retraction in: /10.3892/mmr.2022.12661

MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2

Corrigendum in: /10.3892/mmr.2018.8785 Retraction in /10.3892/mmr.2022.12661

  • Authors:
    • Shichang Cui
    • Yanlei Sun
    • Yang Liu
    • Chengbiao Liu
    • Jinbao Wang
    • Guang Hao
    • Qidong Sun
  • View Affiliations

  • Published online on: October 19, 2017     https://doi.org/10.3892/mmr.2017.7828
  • Pages: 9494-9502
  • Copyright: © Cui et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

A variety of microRNAs (miRs) have been demonstrated to be associated with the development and malignant progression of human cancer; however, the regulatory mechanism of miR‑137 underlying hepatocellular carcinoma (HCC) growth and metastasis still remains to be fully revealed. In the present study, reverse transcription‑quantitative polymerase chain reaction and western blot were used to examine mRNA and protein expression. MTT assay, wound healing assay and Transwell assay were performed to determine cell proliferation, migration and invasion. Luciferase reporter assay was conducted to confirm the targeting relationship. miR‑137 was significantly downregulated in HCC tissues compared to adjacent normal tissues. Low expression of miR‑137 was significantly associated with lymph node metastasis, vein invasion, advanced clinical stage and poor prognosis in HCC. In addition, miR‑137 was also downregulated in several liver cancer cell lines compared with normal liver epithelial cells. Overexpression of miR‑137 led to a significant reduction in cell proliferation, migration and invasion of HepG2 cells. Enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) was further identified as a direct target gene of miR‑137, and the protein expression of EZH2 was negatively regulated by miR‑137 in HepG2 cells. Additionally, EZH2 was significantly upregulated in HCC tissues and liver cancer cell lines. Furthermore, overexpression of EZH2 significantly eliminated the inhibitory effects of miR‑137 on the malignant phenotypes of HepG2 cells. Therefore, the findings suggest that miR‑137 may have a suppressive role in HCC growth and metastasis via targeting EZH2.
View Figures
View References

Related Articles

Journal Cover

December-2017
Volume 16 Issue 6

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Cui S, Sun Y, Liu Y, Liu C, Wang J, Hao G and Sun Q: MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2 Corrigendum in /10.3892/mmr.2018.8785 Retraction in /10.3892/mmr.2022.12661. Mol Med Rep 16: 9494-9502, 2017.
APA
Cui, S., Sun, Y., Liu, Y., Liu, C., Wang, J., Hao, G., & Sun, Q. (2017). MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2 Corrigendum in /10.3892/mmr.2018.8785 Retraction in /10.3892/mmr.2022.12661. Molecular Medicine Reports, 16, 9494-9502. https://doi.org/10.3892/mmr.2017.7828
MLA
Cui, S., Sun, Y., Liu, Y., Liu, C., Wang, J., Hao, G., Sun, Q."MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2 Corrigendum in /10.3892/mmr.2018.8785 Retraction in /10.3892/mmr.2022.12661". Molecular Medicine Reports 16.6 (2017): 9494-9502.
Chicago
Cui, S., Sun, Y., Liu, Y., Liu, C., Wang, J., Hao, G., Sun, Q."MicroRNA‑137 has a suppressive role in liver cancer via targeting EZH2 Corrigendum in /10.3892/mmr.2018.8785 Retraction in /10.3892/mmr.2022.12661". Molecular Medicine Reports 16, no. 6 (2017): 9494-9502. https://doi.org/10.3892/mmr.2017.7828